Universal health services (NYSE: UHS – Get a rating) saw its target price raised by UBS Group investment analysts to $113.00 in a report released on Wednesday, Target Stock Advisor reports. The UBS Group price target indicates a potential decline of 10.54% from the current share price.
A number of other stock analysts have also recently commented on the company. Barclays reduced its target price on universal health services from $133.00 to $115.00 in a Friday, July 29 report. Deutsche Bank Aktiengesellschaft cut its target price on universal health services from $160.00 to $130.00 in a Wednesday July 27 report. Mizuho raised its target price on Universal Health Services from $121.00 to $126.00 and gave the company a “buy” rating in a Wednesday, Nov. 2, report. StockNews.com downgraded Universal Health Services from a “buy” rating to a “hold” rating in a Friday, Nov. 4 research report. Finally, Stephens raised its price target on Universal Health Services to $110.00 and gave the company an “outperform” rating in a Wednesday, July 27 research report. Five analysts rated the stock with a sell rating, four gave the stock a hold rating and three gave the stock a buy rating. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $120.43.
Price performance of universal health services
NYSE UHS traded at $1.31 during Wednesday trading hours, reaching $126.32. The company’s stock had a trading volume of 14,606 shares, compared to an average volume of 910,955. The company has a market capitalization of $9.22 billion, a price-earnings ratio of 13.00, a P /E/G of 4.33 and a beta of 1.29. Universal Health Services has a 1-year minimum of $82.50 and a 1-year maximum of $158.28. The company has a debt ratio of 0.79, a current ratio of 1.27 and a quick ratio of 1.15. The company’s 50-day moving average is $101.26 and its two-hundred-day moving average is $107.81.
Universal health services (NYSE: UHS – Get a rating) last released its quarterly results on Tuesday, October 25. The healthcare provider reported earnings per share of $2.54 for the quarter, beating analyst consensus estimates of $2.40 by $0.14. Universal Health Services had a return on equity of 12.49% and a net margin of 5.59%. The company posted revenue of $3.34 billion in the quarter, versus $3.28 billion expected by analysts. In the same quarter a year earlier, the company posted EPS of $2.67. Universal Health Services quarterly revenue increased 5.7% compared to the same quarter last year. On average, stock analysts predict Universal Health Services will post EPS of 9.84 for the current year.
Hedge funds weigh on universal health services
A number of hedge funds and other institutional investors have recently changed their positions in UHS. Captrust Financial Advisors increased its holdings in Universal Health Services by 9.4% in the third quarter. Captrust Financial Advisors now owns 4,262 shares of the healthcare provider valued at $376,000 after buying an additional 365 shares last quarter. Kentucky Retirement Systems increased its holdings in Universal Health Services by 3.3% in the third quarter. Kentucky Retirement Systems now owns 5,144 shares of the healthcare provider valued at $454,000 after buying an additional 162 shares last quarter. Alpha Paradigm Partners LLC acquired a new stake in Universal Health Services in Q3 valued at approximately $448,000. Balyasny Asset Management LLC acquired a new stake in Universal Health Services in Q3, valued at approximately $765,000. Finally, Verity Asset Management Inc. acquired a new stake in Universal Health Services in Q3 valued at approximately $234,000. Hedge funds and other institutional investors hold 88.93% of the company’s shares.
Universal Health Services Company Profile
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals and ambulatory and behavioral health care facilities. The Company operates through the Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialized surgery, internal medicine, obstetrics, emergency care, radiology, oncology, diagnostic and coronary care, pediatrics, pharmacy and/or behavioral health.
This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Before you consider universal health services, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five actions that top analysts are quietly whispering to their clients to buy now before the market spreads…and Universal Health Services was not on the list.
While Universal Health Services currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.